Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,038 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

IFM 99-02 Thalidomide in Myeloma

NCT00222053

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Médecine Interne, CHU Purpan Toulouse, France
  • Médecine Interne, Hôpital Rangueil Toulouse, France
  • Rhumatologie, CHU Purpan Toulouse, France
  • Rhumatologie, CHU Rangueil Toulouse, France
View Trial Details
Completed

Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma

NCT00179647

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • Alta Bates Cancer Center Berkeley, California, United States
  • Scripps Cancer Center La Jolla, California, United States
  • Cedar Sinai Medical CenterDept of Medicine Los Angeles, California, United States
View all 69 locations
View Trial Details
Completed

MS-275 in Treating Patients With Hematologic Cancer

NCT00015925

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +43 more
Locations
  • Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
View Trial Details

Related conditions